Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. The effects of incretin hormones on cerebral glucose metabolism in health and disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Physiological roles of CNS muscarinic receptors gained from knockout mice

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Blocking of efflux transporters in rats improves translational validation of brain radioligands

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Since its discovery in 1993, the serotonin receptor subtype 7 (5-HT7) has attracted significant attention as a potential drug target; due to its elucidated roles in conditions such as insomnia, schizophrenia, and more. Therefore, it is unsurprising that there has been relatively early efforts undertaken to develop a positron emission tomography (PET) imaging agent for said receptor system. PET can be clinically used to probe receptor systems in vivo, permitting information such as a drug's occupancy against this system to be investigated. This review focuses on the efforts towards the development of a 5-HT7R selective PET CNS tracer over the last 20 years, critically reflecting on applied strategies and commonly employed chemical frameworks and suggests future considerations that are needed to successfully develop a PET tracer for this clinically relevant target. This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.

OriginalsprogEngelsk
Artikelnummer107830
TidsskriftNeuropharmacology
Vol/bind172
Sider (fra-til)107830
ISSN0028-3908
DOI
StatusUdgivet - 1 aug. 2020

Bibliografisk note

Copyright © 2019. Published by Elsevier Ltd.

ID: 60966720